A new Curtin University study has found people diagnosed with sarcoma – a cancer disproportionately affecting teenagers and young adults – are being left without the resources they urgently need.

-Study shows T-cell redirecting therapy can safely be monitored at home, potentially eliminating routine hospitalization after CAR-T and BiTE treatments.

-Outpatient observation cut hospital stays dramatically, with no adverse safety events reported.

-This approach reduces time patients spend away from their families while also freeing up inpatient beds and cutting healthcare costs.

Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of pivekimab sunirine (PVEK), an antibody-drug conjugate targeting CD123, in treating two aggressive blood cancers at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. 

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, presented scientific results on novel therapies, treatment strategies, and approaches to managing side effects and complications for blood cancer patients at the 2025 American Society of Hematology (ASH) conference in Orlando, Florida, held Dec. 6 to 9.

Researchers and clinicians from the Icahn School of Medicine at Mount Sinai will present new discoveries in breast cancer biology, treatment, and real-world patient outcomes at the 2025 San Antonio Breast Cancer Symposium (SABCS), Tuesday-Friday, December 9-12, in San Antonio, Texas.  

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or overweight or obesity.